Virginia Retirement Systems’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Virginia Retirement Systems’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-72,200	Closed	-$871K	–	1192
2019 Q1	$871K	Sell	72,200 -2,100	-3%	-$30.9K	0.01%	724
2018 Q4	$932K	Buy	74,300 +48,600	+189%	+$671K	0.01%	646
2018 Q3	$381K	Buy	25,700 +1,000	+4%	+$15.7K	﹤0.01%	959
2018 Q2	$416K	Buy	+24,700	New	+$480K	0.01%	933
2017 Q3	–	Sell	-15,000	Closed	-$209K	–	1146
2017 Q2	$209K	Sell	15,000 -36,300	-71%	-$535K	﹤0.01%	1006
2017 Q1	$875K	Buy	51,300 +33,400	+187%	+$401K	0.01%	699
2016 Q4	$184K	Buy	17,900 +1,000	+6%	+$9.14K	﹤0.01%	942
2016 Q3	$171K	Buy	+16,900	New	+$185K	﹤0.01%	900

Other funds holding CNCE

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Nuveen Charlotte, North Carolina $369B AUM 31.66% 1-Year Est. Return

Virginia Retirement Systems's CNCE Position: Q2 2019 in Review

Virginia Retirement Systems sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2019, closing a stake of 72,200 shares — an estimated $871K sold.

Virginia Retirement Systems first reported a position in CNCE in Q3 2016 and held it in 8 quarters. The position peaked at $932K in Q4 2018. 87 funds tracked by Wall St. Rank hold CNCE as of Q2 2019.

Virginia Retirement Systems reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2019 after selling out during the quarter.
Virginia Retirement Systems sold 72,200 Concert Pharmaceuticals, Inc. shares in Q2 2019, an estimated $871K.
Virginia Retirement Systems first reported a position in Concert Pharmaceuticals, Inc. in Q3 2016 and held it in 8 quarters.
Virginia Retirement Systems's Concert Pharmaceuticals, Inc. position peaked at $932K in Q4 2018.
87 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2019.

Based on Virginia Retirement Systems's 13F filing for Q2 2019, filed 26 Jul 2019.